Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

InteliScript's Market Disruptive Technology Built to Save Patients-Carriers-Payors Billions of Dollars Annually
  • USA - English


News provided by

InteliScript, LLC

Nov 29, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX

HCP and Patient jointly choose the lowest cost drug therapy
HCP and Patient jointly choose the lowest cost drug therapy

Las Vegas Nevada (PRWEB) November 29, 2016 -- InteliScript, LLC, a world class healthcare technology and software development company today announced the formal integration and deployment launch of its “real-time” and market disruptive “Point-of-Care/Price Compare” software platform, across multiple top-10 electronic medical and health record systems nationally reaching hundreds of thousands of healthcare providers, hospitals and clinics.

These mobile applications and cards include significant drug ingredient spreads and admin fees that are filling the pockets of the PBM’s and their marketing partners administrating these programs to the tune of billions of dollars annually.

Post this

InteliScript’s proprietary software and processes integrate directly within the e-Prescribing workflow of EMR/EHR systems delivering “real-time drug pricing” and “real-time benefit check” capabilities to confront and reduce the rising costs of prescription medications realized by millions of Patients and Insurance Carriers/Payors.

InteliScript’s software platform and solutions will deliver billions of dollars of annual savings to both Patients and insurance Carriers/Payors by bringing true prescription price transparency within the e-Prescribing workflow and during the encounter between the Patient and their healthcare provider.

“Our #1 objective when we embarked in the development of our technology was to deliver the absolute lowest prescription cost to Patients and Carriers/Payors alike and to disrupt the market status quo. InteliScript discovered early on that Patients are subject to high insurance copays, deductibles, and drug plan exclusions and through extensive research conducted by InteliScript, it has shown that these same Patients and consumers have been targeted and inundated with advertising for prescription drug discount cards and mobile applications containing prescription drug discount cards from a plethora of PBM’s and marketing companies over the last 10+ years.InteliScript discovered through its own use of these mobile applications and discount cards that they promise discounts as high as 96% of which were very rarely if ever realized. With our management team having extensive experience in the PBM industry, Patients and consumers in general don’t realize that the prices that they are paying when using these mobile applications and cards include significant drug ingredient spreads and admin fees that are filling the pockets of the PBM’s and their marketing partners administrating these programs to the tune of billions of dollars annually,” said Thomas Borzilleri, Inventor and acting CEO of InteliScript.

Ingredient spreads, (the markup and difference between the PBM’s contract rate they hold with the pharmacy and what the Patient pays) coupled with admin fees that are added to the total prescription price (the admin fee market range average is $5.00 to as high as $15.00 per prescription) artificially drives up the final combined cost to the Patient by as much as 60% or more on each prescription.

  • InteliScript maintains a “no spread” contract rate and model across 64,000+ Pharmacy Chains and Independents nationally delivering the absolute lowest price to the Patient with prices delivered lower than any drug discount mobile application or card in the market.
  • Point-of-Care/Price Compare also analyzes the Patient’s benefit levels of their insurance coverage in “real-time” and in many instances, can deliver a cash price, especially on Generic drugs, that is below the copay under their plan.
  • InteliScript’s technology takes it one step further by analyzing and displaying the 5 lowest priced pharmacies geographically located nearest to the Patient’s residence in “real-time” and directly on the EMR/EHR screen allowing the Patient and their health care provider to jointly choose the lowest cost option as contract rates vary across pharmacy chains, grocery stores, and Independent pharmacies.

Through this technology, InteliScript has now eliminated the need for a mobile application, card, voucher, or coupon for presentation to the pharmacy entirely, thus reducing the workflow for the pharmacist and their staff. With this level of price transparency, the Patient now knows exactly what the cost of the prescription is and to determine if the prescribed therapy is affordable within the office encounter. This capability enables the Patient to be directly engaged in their healthcare decisions in concert with their healthcare provider which will drive adherence, compliance, the lowering overall abandonment rates, and as a result, delivering improved health outcomes.

Alternative Drug Solution, an Alliance Between Practitioner, Carrier, Payor, and Patient........

InteliScript’s revolutionary “Alternative Drug Solution” was designed specifically to address the insurance Carrier and Payor market by revealing the identity of the prescribed drug in “real-time” while determining and instantly selecting a clinically and therapeutically equivalent drug that delivers the absolute lowest ingredient cost and contract rate to the insurance Carrier/Payor. Healthcare professionals generally prescribe therapies based on both the Patient’s condition and their familiarity of a specific drug treatment. On the other hand, insurance carriers have no idea what a healthcare professional has prescribed until after they have received and paid the claim. InteliScript’s proprietary software and platform bridges this gap allowing for “real-time” interaction of both stakeholders at the point-of-care; within the e-Prescribing workflow delivering an alternative preferred drug that will deliver the absolute lowest cost to the insurance Carrier/Payor.

“This year, a published 3-year study of top 5 insurance carriers determined that the substitution of an alternative and clinically equivalent drug versus what was originally prescribed by the healthcare provider would have delivered a savings to the carriers of more than $73 billion dollars over the same period,” said Borzilleri. “Our software and processes were developed to address this specific issue. We are first to market with this highly capable and disruptive technology and we look forward to delivering additional and continued savings to millions of Patients and associated stakeholders in the healthcare value chain to lower overall healthcare costs”.

About Inteliscript:

InteliScript is a US based world class technology and software systems development company specializing in healthcare. InteliScript's technological capabilities unlock the power of data to drive better insights and results making them actionable while cutting through the complexity tapping the full potential of Big Data with ease. InteliScript uses data in new ways to improve processes that drive interactive success through more precise Patient data analytics and do it all with products architected for the healthcare industry-leading speed, efficiency and simplicity. Our systems master data, maximize data quality and integration, capture, transform and link structured and unstructured data from virtually any source or data repository – across the domains of physical, social, ecommerce, and mobile – to gain insight and drive more effective business decisions all in "real-time."

Contact & Press Inquiries: InteliScript, LLC
Thomas Borzilleri, Inventor
Email: info(at)inteliscript(dot)com
PH: 949-342-0209
http://www.inteliscript.com

Thomas Borzilleri, InteliScript, LLC, http://www.inteliscript.com, +1 (949) 342-0209, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.